XML 84 R64.htm IDEA: XBRL DOCUMENT v3.25.0.1
EQUITY (Tables)
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Schedule of Stock by Class
Preferred stock authorized, issued and outstanding was as follows:
December 31,
20242023
SeriesShares AuthorizedShares
 Issued		Shares OutstandingShares AuthorizedShares
 Issued		Shares Outstanding
Series A 32,000 32,000 32,000 32,000 32,000 32,000 
Series B 20,000 17,773 17,773 20,000 20,000 20,000 
Series C12,000 12,000 12,000 12,000 12,000 12,000 
Total64,000 61,773 61,773 64,000 64,000 64,000 
Schedule of Dividends Declared
Dividends declared per share were as follows for the periods indicated:
Year ended December 31,
202420232022
Series A dividends declared $1,313 $1,313 $1,313 
Series B dividends declared$1,238 $1,238 $1,238 
Series C dividends declared$1,075 $1,075 $1,075 
Dividends declared per share of common stock were as follows for the periods indicated:
Year Ended December 31,
202420232022
Dividends declared$0.94 $0.86 $0.78 
Schedule of Accumulated Other Comprehensive Income (Loss) The balances were as follows:
 
December 31,
20242023
 
(in millions)
Unrealized gains (losses) on investments$(7,334)$(6,638)
Market risk benefits - instrument-specific credit risk component(1,125)(633)
Liability for future policy benefits - current discount rate component372 182 
Defined benefit pension plans(579)(652)
Foreign currency translation adjustments(88)(76)
Total accumulated other comprehensive income (loss)(8,754)(7,817)
Less: Accumulated other comprehensive income (loss) attributable to noncontrolling interest(42)(40)
Accumulated other comprehensive income (loss) attributable to Holdings$(8,712)$(7,777)
Schedule of Components of Accumulated Other Comprehensive Income (Loss), Net of Taxes
The components of OCI, net of taxes were as follows:
Year Ended December 31,
202420232022
(in millions)
Change in net unrealized gains (losses) on investments:
Net unrealized gains (losses) arising during the period (1)
$(874)$1,954 $(13,637)
(Gains) losses reclassified into net income (loss) during the period (2)
47 445 685 
Net unrealized gains (losses) on investments(827)2,399 (12,952)
Adjustments for policyholders’ liabilities, insurance liability loss recognition and other
67 (22)346 
Change in unrealized gains (losses), net of adjustments (net of
deferred income tax expense (benefit) of $(224), $206 and $(1,364))
(760)2,377 (12,606)
Change in LFPB discount rate and MRB credit risk, net of tax
Changes in market risk benefits - instrument-specific credit risk (net of
deferred income tax expense (benefit) of $(103), $(273)and $332)
(389)(1,027)1,249 
Changes in liability for future policy benefits - current discount rate (net of
deferred income tax expense (benefit) of $40, $(36) and $285)
150 (137)1,074 
Change in defined benefit plans:
Reclassification to Net income (loss) of amortization of net prior service credit included in net periodic cost (3)73 (3)18 
Change in defined benefit plans (net of deferred income tax expense
(benefit) of $18, $3 and $(1) )
73 (3)18 
Foreign currency translation adjustments:
Foreign currency translation gains (losses) arising during the period(11)15 (46)
Foreign currency translation adjustment(11)15 (46)
Total other comprehensive income (loss), net of income taxes(937)1,225 (10,311)
Less: Other comprehensive income (loss) attributable to noncontrolling interest(2)10 (16)
Other comprehensive income (loss) attributable to Holdings$(935)$1,215 $(10,295)
______________
(1)For 2022, unrealized gains (losses) arising during the period is presented net of a valuation allowance of $1.6 billion established during the fourth quarter of 2022. The Company established the valuation allowance against its deferred tax assets related to unrealized capital losses in the available for sale securities portfolio. As of December 31, 2024 and 2023, a valuation allowance of $217 million and $234 million, respectively, remains against the portion of the deferred tax asset that is still not more-likely-than-not to be realized. See Note 18 of the Notes to these Consolidated Financial Statements for details on the valuation allowance.
(2)See “Reclassification adjustment” in Note 3 of the Notes to these Consolidated Financial Statements. Reclassification amounts presented net of income tax expense (benefit) of $(12) million, $(118) million, and $(182) million for the years ended December 31, 2024, 2023 and 2022, respectively.
(3)These AOCI components are included in the computation of net periodic costs. See Note 16 of the Notes to these Consolidated Financial Statements.